By asianet
– Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa – Early customers include GP offices and other community-based healthcare settings – Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and nearly half are undiagnosed[1] – The LumiraDx … Continued
By asianet
Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supports opaganib’s potential as a nuclear radiation injury therapeutic for homeland security material threat medical countermeasures (MCM) and for antitumor radiotherapy As an oral, small molecule pill that is highly stable with a more than five-year … Continued
By asianet
Sentinel CH. SpA today announced the launch of SENTiNAT(R) 200, the fully automated sample to result system, and SENT-NAT(R) SN200 Real-Time PCR assays for the quantitative detection of 10 viruses. SENTiNAT(R) 200 and STAT-NAT(R) SN200 kits represent the ideal solution for mid to large throughput laboratories engaged in the diagnosis of viral infections. SENTiNAT(R) 200 … Continued
By asianet
– Substantial investment of USD119 million achieved by TauRx through a warrants exercise triggered by the announcement of LUCIDITY results in October, supporting HMTM regulatory submissions in UK, US and Canada, and preparation for market availability – Shareholder commitment to TauRx represents a significant success story for UK-based life sciences research and development in areas … Continued
By asianet
Lotus Pharmaceutical (1795: TT), a multinational pharmaceutical company, today reported its financial results for the third quarter ended 30 September 2022. Third quarter financial highlights: – Third quarter 2022 is the best quarter ever in the Company’s history, majorly driven by the successful launch of Lenalidomide in the US – the biggest launch in Lotus … Continued
By asianet
INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects in animal models TES Pharma is dedicated to the identification of novel therapeutic targets and the discovery and development of new molecules to efficiently address the needs of patients with … Continued
By asianet
— The Novavax BA.1 vaccine candidate met its primary strain-change endpoint allowing for development of variant vaccines, if necessary — Novavax’ prototype vaccine induced broad immune response against original Wuhan, BA.1, and BA.5 strains — The trial showed no benefit for a bivalent vaccine utilizing Novavax’ recombinant protein/adjuvant technology Novavax, Inc. (Nasdaq: NVAX), a biotechnology … Continued
By asianet
– The ambitious EU initiative has already secured 2 billion euros of co-investment capabilities and has supported 60 innovative Biotech, Medtech & digital health start-ups to get to market or expand into new territories. – EIT Health, co-operator of the Venture Centre of Excellence alongside the European Investment Fund (EIF), has named ProductLife Group the … Continued
By asianet
OMRON Corporation headquartered in Shimogyo-ku, Kyoto, became a member of The Climate Group’s “EP100” (*1) initiatives. OMRON is the first Japanese company in the manufacturing industry and the fourth Japanese company in general to join the EP100 initiative, which brings together over 120 energy smart businesses committed to measuring and reporting on energy efficiency improvements. … Continued
By asianet
— Seasoned Executive has Successful Track Record Working with Global Investors to Raise Billions of Dollars Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced it has appointed Richard “Ric” Peterson as chief financial officer. Photo – https://mma.prnewswire.com/media/1935041/Turn_Biotechnologies_Ric_Peterson.jpg Logo – https://mma.prnewswire.com/media/1935529/TURN_LOGO_HI_RES_Logo.jpg Mr. Peterson, who has served as … Continued